|
1
|
Kitzman DW, Brubaker P, Morgan T,
Haykowsky M, Hundley G, Kraus WE, Eggebeen J and Nicklas BJ: Effect
of caloric restriction or aerobic exercise training on peak oxygen
consumption and quality of life in obese older patients with heart
failure with preserved ejection fraction: A randomized clinical
trial. JAMA. 315:36–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhong M, Zhou H, Long C, Zhang Y, Cui W,
Zhang H and Wang H: Natakalim ameliorates isoproterenol-induced
chronic heart failure by protecting against endothelial
dysfunction. Pharmacology. 98:99–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang GX, Ohmori K, Nagai Y, Fujisawa Y,
Nishiyama A, Abe Y and Kimura S: Role of AT1 receptor in
isoproterenol-induced cardiac hypertrophy and oxidative stress in
mice. J Mol Cell Cardiol. 42:804–811. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sente T, Van Berendoncks AM, Jonckheere
AI, Rodenburg RJ, Lauwers P, Van Hoof V, Wouters A, Lardon F,
Hoymans VY and Vrints CJ: Primary skeletal muscle myoblasts from
chronic heart failure patients exhibit loss of anti-inflammatory
and proliferative activity. BMC Cardiovasc Disord. 16:1072016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cabassi A, Binno SM, Tedeschi S, Graiani
G, Galizia C, Bianconcini M, Coghi P, Fellini F, Ruffini L, Govoni
P, et al: Myeloperoxidase-related chlorination activity is
positively associated with circulating ceruloplasmin in chronic
heart failure patients: Relationship with neurohormonal,
inflammatory and nutritional parameters. Biomed Res Int.
2015:6916932015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brouwers C, Kupper N, Pelle AJ, Szabó BM,
Westerhuis BL and Denollet J: Depressive symptoms in outpatients
with heart failure: Importance of inflammatory biomarkers, disease
severity and personality. Psychol Health. 29:564–582. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brouwers C, Mommersteeg PM, Nyklíček I,
Pelle AJ, Westerhuis BL, Szabó BM and Denollet J: Positive affect
dimensions and their association with inflammatory biomarkers in
patients with chronic heart failure. Biol Psychol. 92:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ranganathan P, Jayakumar C, Tang Y, Park
KM, Teoh JP, Su H, Li J, Kim IM and Ramesh G: MicroRNA-150 deletion
in mice protects kidney from myocardial infarction-induced acute
kidney injury. Am J Physiol Renal Physiol. 309:F551–F558. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bodén S, Wennberg M, Van Guelpen B,
Johansson I, Lindahl B, Andersson J, Shivappa N, Hebert JR and
Nilsson LM: Dietary inflammatory index and risk of first myocardial
infarction; a prospective population-based study. Nutr J.
16:212017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
D'Amario D, Cabral-Da-Silva MC, Zheng H,
Fiorini C, Goichberg P, Steadman E, Ferreira-Martins J, Sanada F,
Piccoli M, Cappetta D, et al: Insulin-like growth factor-1 receptor
identifies a pool of human cardiac stem cells with superior
therapeutic potential for myocardial regeneration. Circ Res.
108:1467–1481. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu LJ, Ren WY, Shen QJ, Ji HY and Zhu L:
Inflammation in lung after acute myocardial infarction is induced
by dendritic cell-mediated immune response. J Biol Regul Homeost
Agents. 31:29–40. 2017.PubMed/NCBI
|
|
12
|
Rocha JA, Ribeiro SP, França CM, Coelho O,
Alves G, Lacchini S, Kallás EG, Irigoyen MC and Consolim-Colombo
FM: Increase in cholinergic modulation with pyridostigmine induces
anti-inflammatory cell recruitment soon after acute myocardial
infarction in rats. Am J Physiol Regul Integr Comp Physiol.
310:R697–R706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu L, Mei L, Chong L, Huang Y, Li Y, Chu M
and Yang X: Olmesartan ameliorates pressure overload-induced
cardiac remodeling through inhibition of TAK1/p38 signaling in
mice. Life Sci. 145:121–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li CY, Zhou Q, Yang LC, Chen YH, Hou JW,
Guo K, Wang YP and Li YG: Dual-specificity phosphatase 14 protects
the heart from aortic banding-induced cardiac hypertrophy and
dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling
pathway. Basic Res Cardiol. 111:192016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao Y, Ruan Y, Shen T, Huang X, Li M, Yu
W, Zhu Y, Man Y, Wang S and Li J: Astragalus polysaccharide
suppresses doxorubicin-induced cardiotoxicity by regulating the
PI3k/Akt and p38MAPK pathways. Oxid Med Cell Longev.
2014:6742192014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou S, Fang M, Zhu Q, Liu Y, Liu L and Li
X: MicroRNA-939 governs vascular integrity and angiogenesis through
targeting γ-catenin in endothelial cells. Biochem Biophys Res
Commun. 484:27–33. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Häyry P, Aavik E and Myllärniemi M:
Blockade of growth factor synthesis and growth factor action: Two
possible sites of interference in allograft vessel disease and
coronary bypass or balloon injury. Metabolism. 45 8 Suppl
1:S101–S103. 1996. View Article : Google Scholar
|
|
18
|
Delafontaine P, Song YH and Li Y:
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1
binding proteins in blood vessels. Arterioscler Thromb Vasc Biol.
24:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang H, Zhang FF, Peng XH, Zhao DH and
Peng J: Efficacy of medication directed by home-monitoring cardiac
resynchronization therapy in chronic heart failure patients. Chin
Med Sci J. 29:61–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vergaro G, Prud'homme M, Fazal L, Merval
R, Passino C, Emdin M, Samuel JL, Solal Cohen A and Delcayre C:
Inhibition of galectin-3 pathway prevents isoproterenol-induced
left ventricular dysfunction and fibrosis in mice. Hypertension.
67:606–612. 2016.PubMed/NCBI
|
|
21
|
Pitt B, Anker SD, Böhm M, Gheorghiade M,
Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, et
al: Rationale and design of MinerAlocorticoid Receptor antagonist
Tolerability Study-Heart Failure (ARTS-HF): A randomized study of
finerenone vs. Eplerenone in patients who have worsening chronic
heart failure with diabetes and/or chronic kidney disease. Eur J
Heart Fail. 17:224–232. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Javan H, Szucsik AM, Li L, Schaaf CL,
Salama ME and Selzman CH: Cardiomyocyte p65 nuclear factor-κB is
necessary for compensatory adaptation to pressure overload. Circ
Heart Fail. 8:109–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao W, Chen J, Chen Y, Chen S, Chen X,
Huang H and Liu P: Advanced glycation end products induced immune
maturation of dendritic cells controls heart failure through NF-κB
signaling pathway. Arch Biochem Biophys. 580:112–120. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Killeen MJ, Linder M, Pontoniere P and
Crea R: NF-κβ signaling and chronic inflammatory diseases:
Exploring the potential of natural products to drive new
therapeutic opportunities. Drug Discov Today. 19:373–378. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maier HJ, Schips TG, Wietelmann A, Krüger
M, Brunner C, Sauter M, Klingel K, Böttger T, Braun T and Wirth T:
Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces
reversible inflammatory cardiomyopathy and heart failure. Proc Natl
Acad Sci USA. 109:11794–11799. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siman FD, Silveira EA, Fernandes AA,
Stefanon I, Vassallo DV and Padilha AS: Ouabain induces nitric
oxide release by a PI3K/Akt-dependent pathway in isolated aortic
rings from rats with heart failure. J Cardiovasc Pharmacol.
65:28–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui J, Zhang F, Wang Y, Liu J, Ming X, Hou
J, Lv B, Fang S and Yu B: Macrophage migration inhibitory factor
promotes cardiac stem cell proliferation and endothelial
differentiation through the activation of the PI3K/Akt/mTOR and
AMPK pathways. Int J Mol Med. 37:1299–1309. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sagara S, Osanai T, Itoh T, Izumiyama K,
Shibutani S, Hanada K, Yokoyama H, Yamamoto Y, Yokota T, Tomita H,
et al: Overexpression of coupling factor 6 attenuates
exercise-induced physiological cardiac hypertrophy by inhibiting
PI3K/Akt signaling in mice. J Hypertens. 30:778–786. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun GW, Qiu ZD, Wang WN, Sui X and Sui DJ:
Flavonoids extraction from propolis attenuates pathological cardiac
hypertrophy through PI3K/AKT signaling pathway. Evid Based
Complement Alternat Med. 2016:62813762016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He SF, Jin SY, Wu H, Wang B, Wu YX, Zhang
SJ, Irwin MG, Wong TM and Zhang Y: Morphine preconditioning confers
cardioprotection in doxorubicin-induced failing rat hearts via
ERK/GSK-3β pathway independent of PI3K/Akt. Toxicol Appl Pharmacol.
288:349–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim SJ, Yoo KY, Jeong CW, Kim WM, Lee HK,
Bae HB, Kwak SH, Li M and Lee J: Urinary trypsin inhibitors afford
cardioprotective effects through activation of PI3K-Akt and ERK
signal transduction and inhibition of p38 MAPK and JNK. Cardiology.
114:264–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaur M, Ritner C, Sievers R, Pedersen A,
Prasad M, Bernstein HS and Yeghiazarians Y: Timed inhibition of
p38MAPK directs accelerated differentiation of human embryonic stem
cells into cardiomyocytes. Cytotherapy. 12:807–817. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sucharov CC: Role of p38MAPK in
beta(2)AR-induced cardiomyopathy: At the heart of the matter?
Future Cardiol. 3:387–389. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Xiao X, Shen Y, Chen L, Xu C, Zhao
H, Wu Y, Zhang Q, Zhong J, Tang Z, et al: MicroRNA-32 promotes
calcification in vascular smooth muscle cells: Implications as a
novel marker for coronary artery calcification. PLoS One.
12:e01741382017. View Article : Google Scholar : PubMed/NCBI
|
